Arbutus Biopharma Corporation · NASDAQ:ABUS
Whitefort Capital Master Fund, LP reported a 7.00% stake in Arbutus Biopharma Corporation (Schedule 13D/A)
Event Feb 20, 2025 · Filed Feb 21, 2025
Whitefort Capital Master Fund, LP reported a 7.00% stake in Arbutus Biopharma Corporation, 13,307,967 shares, with active intent on Feb 20, 2025. Filed Feb 21, 2025 (Schedule 13D/A).
- Stake
- 7.00%
- Shares
- 13,307,967
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Whitefort Capital Master Fund, LP | 7.00% | 13,307,967 |
| Whitefort Capital GP, LLC | 7.00% | 13,307,967 |
| Whitefort Capital Management, LP | 7.00% | 13,307,967 |
| Whitefort Capital Management GP, LLC | 7.00% | 13,307,967 |
| David Salanic | 7.00% | 13,307,967 |
| Joseph Kaplan | 7.00% | 13,307,967 |
Source
Related
- Arbutus Biopharma Corporation
- Whitefort Capital Master Fund, LP
- Arbutus Biopharma Corporation shareholders
- Schedule 13D/A · Whitefort Capital Master Fund, LP · Apr 28, 2026
- Schedule 13D/A · Whitefort Capital Master Fund, LP · Apr 13, 2026
- Form 4 · Androski Lindsay · Oct 7, 2026
- Form 4 · Sawhney Roger · Oct 7, 2026
- Form 4 · Nguyen Tuan · Oct 7, 2026
- Form 4 · Beardsley Robert A · Oct 7, 2026
- Schedule 13G/A · Morgan Stanley · Oct 7, 2026